BOUNDLESS BIO, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BOUNDLESS BIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $36.00K.
- BOUNDLESS BIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $59.00K, a 90.32% increase year-over-year.
- BOUNDLESS BIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $86.00K.
- BOUNDLESS BIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $26.00K.
- BOUNDLESS BIO, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $62.00K, a 65.93% decline from fiscal 2023.
- BOUNDLESS BIO, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $182.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $36.00K 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $62.00K 10-K · filed 2026-03-09 | |
| 2024-03-31 | $59.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $182.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $86.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $26.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $31.00K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |